141 related articles for article (PubMed ID: 4012)
1. In vitro susceptibility studies with josamycin and erythromycin.
Strausbaugh LJ; Dilworth JA; Gwaltney JM; Sande MA
Antimicrob Agents Chemother; 1976 Mar; 9(3):546-8. PubMed ID: 4012
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of dirithromycin (LY 237216) compared with activities of other macrolide antibiotics.
Yu KW; Neu HC
Antimicrob Agents Chemother; 1990 Sep; 34(9):1839-42. PubMed ID: 2126695
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of josamycin and rosamicin against Bacteroides fragilis compared with clindamycin, erythromycin, and metronidazole.
Santoro J; Kaye D; Levison ME
Antimicrob Agents Chemother; 1976 Jul; 10(1):188-90. PubMed ID: 984752
[TBL] [Abstract][Full Text] [Related]
4. [Studies on susceptibility of isolated organisms from pediatric infections against various antimicrobial agents].
Fujii R; Shinozaki T; Meguro H; Arimasu O; Yoshioka H; Fujita K; Sakata H; Maruyama S; Wagatsuma Y; Fukushima N
Jpn J Antibiot; 1988 Jul; 41(7):841-53. PubMed ID: 3050184
[TBL] [Abstract][Full Text] [Related]
5. Josamycin and rosamicin: in vitro comparisons with erythromycin and clindamycin.
Shadomy S; Tipple M; Paxton L
Antimicrob Agents Chemother; 1976 Oct; 10(4):773-5. PubMed ID: 984811
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial activity of the new macrolide flurithromycin against Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, Branhamella catarrhalis and Staphylococcus aureus.
Nord CE; Lindmark A; Persson I
J Chemother; 1989 Jul; 1(4 Suppl):203-4. PubMed ID: 16312369
[No Abstract] [Full Text] [Related]
7. The comparative in vitro activity of spiramycin and erythromycin against Norwegian bacterial isolates.
Dibb WL; Ragnhildstveit E
NIPH Ann; 1986 Dec; 9(2):61-3. PubMed ID: 3101004
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of josamycin against aerobic gram-positive cocci and anaerobes.
Westerman EL; Williams TW; Moreland N
Antimicrob Agents Chemother; 1976 Jun; 9(6):988-93. PubMed ID: 7189
[TBL] [Abstract][Full Text] [Related]
9. [In vitro activity of josamycin in a comparison of Staphylococcus aureus, Streptococcus pyogenes and Streptococcus pneumoniae].
Andreoni O
Minerva Med; 1983 Mar; 74(12):619-24. PubMed ID: 6339995
[TBL] [Abstract][Full Text] [Related]
10. In-vitro activity of roxithromycin against respiratory and skin pathogens.
Pechére JC; Auckenthaler R
J Antimicrob Chemother; 1987 Nov; 20 Suppl B():1-5. PubMed ID: 3501424
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro activity of A-56268 against respiratory tract pathogens.
Jansson L; Kalin M
Eur J Clin Microbiol; 1987 Aug; 6(4):494-6. PubMed ID: 2959474
[No Abstract] [Full Text] [Related]
12. Josamycin: interpretation of inhibition zones with the Bauer-Kirby agar disk diffusion test as compared with erythromycin.
Karthein J; Spohr M; Traub WH
Chemotherapy; 1986; 32(4):336-43. PubMed ID: 3731919
[TBL] [Abstract][Full Text] [Related]
13. [In vitro activity of roxithromycin against hospital bacteria and the concordance curve].
Soussy CJ; Chanal M; Kitzis MD; Duval J; Cluzel R; Acar JF
Pathol Biol (Paris); 1988 May; 36(5):420-4. PubMed ID: 2900488
[TBL] [Abstract][Full Text] [Related]
14. Comparison of selection for mutants with reduced susceptibility to ABT-773, erythromycin and rifampicin in respiratory tract pathogens.
Nilius AM; Hensey-Rudloff DM; Reimann MA; Flamm RK
J Antimicrob Chemother; 2002 May; 49(5):831-6. PubMed ID: 12003979
[TBL] [Abstract][Full Text] [Related]
15. In vitro killing kinetics and postantibiotic effect of josamycin and other macrolides on several bacteria.
Minguez F; Ramos C; Loscos A; Chiu ML; Prieto J
Chemotherapy; 1993; 39(3):163-8. PubMed ID: 8389685
[TBL] [Abstract][Full Text] [Related]
16. [Studies on josamycin. 3. (1) Bacteriological studies. (2) Protective effect against infections due to pathogenic bacteria. (3) Absorption, excretion, distribution in organs and in vivo activities].
Osono T; Yano K; Mitamoto F; Watanabe S; Ishida H
Jpn J Antibiot; 1969 Apr; 22(2):159-72. PubMed ID: 4389777
[No Abstract] [Full Text] [Related]
17. The in vitro responses of Bacteroides fragilis to Moxalactam, Cefotaxime, Cefmetazole, Josamycin and erythromycin.
Soriano F; Ponte MC; Gaspar MC
J Clin Pathol; 1982 Oct; 35(10):1166-7. PubMed ID: 6290543
[No Abstract] [Full Text] [Related]
18. Comparative antimicrobial activity of the new macrolide flurithromycin against respiratory pathogens.
Nord CE; Lindmark A; Persson I
Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):71-3. PubMed ID: 3132384
[TBL] [Abstract][Full Text] [Related]
19. In vitro susceptibility of common clinical anaerobic and aerobic isolates against josamycin.
Reese RE; Betts RF; Goedde LW; Douglas RG
Antimicrob Agents Chemother; 1976 Aug; 10(2):253-7. PubMed ID: 984766
[TBL] [Abstract][Full Text] [Related]
20. Effects of carbon dioxide upon the in vitro activity of erythromycin.
Dibb WL; Digranes A; Bottolfsen KL
Acta Pathol Microbiol Immunol Scand B; 1986 Jun; 94(3):173-6. PubMed ID: 3090858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
